Clinical Trial Update: Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating fecal microbiota transfer for progression of Parkinson disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Fecal Microbiota Transfer (fecal microbiota transplantation)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED